On Demand 2023 Sunday PM General Sessions
This collection covers general sessions from Sunday's program. This includes plenaries, and symposia. The sessions listed below are included in this package:
- Primary Prevention Strategies for Asthma
- ProCon - Skin Testing vs Serum Testing for the Diagnosis of Venom Allergy
- Jeopardy - What's That Rash?
- Introductory Course in Rhinolaryngoscopy
- Allergen Immunotherapy in Your Practice - Are You Up to Date with the Current Parameters?
- An Ounce of Prevention in Food Allergy
- The Ever-Changing Landscape of COVID-19
The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American College of Allergy, Asthma & Immunology (ACAAI) designates this enduring material for a maximum of 11 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Medical professionals who treat patients with allergic and/or immunological conditions:
- Practicing allergist/immunologists
- Allergy/immunology Fellows-in-Training
- Physician assistants
- Nurses and advanced practice nurses
- Allied health professionals
- Primary care physicians
- Other medical professionals
Upon completion of this session, participants should be able to:
- Define basic dermatology terms.
- Differentiate between skin lesions that have a similar appearance.
- Develop appropriate treatment plans.
- Identify the relative merits of venom skin and serum testing.
- Indicate the relative merits of component venom testing.
- Describe the major anatomical findings in the upper airway.
- Identify normal and abnormal anatomy, disease presentations and post-op findings.
- Appraise indications for use of the rhinoscope in the allergist's office.
- Extrapolate the role that microbial exposures (including infection and colonization) play in the development of asthma.
- Calculate the role that maternal health and exposures, as well as childhood obesity and diet, play in the development of asthma.
- Review the evidence for airborne/inhalational exposures influencing the development of asthma, as well as medication that may have a role in asthma prevention.
- Analyze available data on SCIT and SLIT and discuss risks of both therapies.
- Summarize current recommendations on patient selection and allergen dosing in allergy immunotherapy.
- Describe available tools to help identify efficacy, safety, and quality of life outcomes in patients on allergy immunotherapy.
- Describe the role of early food introduction for allergenic foods and how to provide practical advice for families.
- Discuss the role of the skin barrier in food allergy development and prevention.
- Highlight future approaches in preventing food allergy.
- Summarize the latest updates in management of outpatient COVID.
- Distinguish manifestations of long COVID and provide an update on the science of this complicated condition.
- Appraise recent trends in pediatric and adult vaccination, and how they may relate to the COVID-19 pandemic.
Jeremy S. Katcher, MD, FACAAI
Justin C. Greiwe, MD, FACAAI
Andrew L. Kau, MD, PhD
Thomas AE Platts-Mills, MD, PhD, FACAAI
Wanda Phipatanakul, MD, MS, FACAAI
James M. Tracy, DO, FACAAI
David B.K. Golden, MDCM, FACAAI
Karla Adams, MD, FACAAI
David R. Stukus, MD, FACAAI
Kelly M. Maples, MD, FACAAI
Luz S. Fonacier, MD, FACAAI
Anitha Shrikhande, MD
Andrew Alexis, MD, MPH
Jerald W. Koepke, MD, FACAAI
Seong H. Cho, MD, FACAAI
Robert J. Szalewski, MD
Nicole E. Barberis, MD
Maureen M. Petersen, MD, FACAAI
Anne K. Ellis, MD, MSc, FACAAI
Dennis Keith Ledford, MD, FACAAI
Robert Sporter, MD, FACAAI
Jing Yi (Jenny) Sun, MD
Elissa Michele Abrams, MD MPH FRCPC
Christina E. Ciaccio, MD, MSc, FACAAI
Helen A. Brough, MD PhD FAAAAI
Niraj C. Patel, MD, MS, FACAAI
Joseph P. Forester, DO, FACAAI
Syed Shahzad Mustafa, MD, FACAAI
Purvi S. Parikh, MD, FACAAI
Paul V. Williams, MD, FACAAI
- 11.00 AMA PRA Category 1 Credit™
- 11.00 Attendance
- 11.00 CBRN